Head-to-head for women
Hims & Hers vs REMEVi
Hims & Hers and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Hims & Hers
Ranked #40 for women · Grade B
Luna Fit
Best for: Women who want a familiar, app-driven consumer brand with an explicit women's (Hers) front door.
FDA warning letterSeptember 2025Read it ↗Visit Hims & HersREMEVi
Higher scoreRanked #31 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViThe verdict for women
REMEVi edges out Hims & Hers on the Luna Fit Score, 85 to 83 (B vs B). Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. The reasoning behind that number is in the REMEVi scorecard.
Hims & Hers is still a genuine option — the Hers side is one of the few mass-market brands built around a women's identity — app-first, nationwide, though its hormonal depth is thin. Weigh the six women's-health factors below against your own priorities; what we found reviewing Hims & Hers goes through each of them, and if neither of these two is the one, our ranked shortlist of Hims & Hers alternatives widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Hims & Hers | REMEVi |
|---|---|---|
| Luna Fit Score | 83/100 · B | 85/100 · B |
| Overall rank | #40 | #31 |
| Semaglutide | $199/mo | $199/mo |
| Tirzepatide | Not disclosed | $269/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Luna Fit
Hims & Hers
Ranked #40 · Grade B
What we like
- Explicit women-focused (Hers) positioning and brand trust
- Nationwide with a slick app experience
- Simple, mass-market onboarding
The caveats
- Tirzepatide pricing not consistently disclosed
- Limited hormonal/PCOS depth behind the branding
Luna Fit
REMEVi
Ranked #31 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Hims & Hers nor REMEVi is only worth comparing with the other. Hims & Hers is also written up against Eden, 5 points apart on the Luna Fit Score — see Hims & Hers against Eden, factor by factor. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.
- Hims & Hers vs CoreAge Rx
- Hims & Hers vs Enhance MD
- Hims & Hers vs yourEra
- REMEVi vs Sesame Care
- REMEVi vs HealthRX
- REMEVi vs MadeMed
Or browse the full comparison hub.